Chimerix Inc
Chimerix Inc logo
CMRX

Chimerix Inc (CMRX)

$2.221.33%

Market is closed
– opens on 8 PM, 06 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$2.185
Day's Range
$2.32
$1.27
52-Week Range
$7.42
1 month return14.43%
3 month return6.73%
1 year return63.31%
5 year return49.89%

Company Information

Chimerix is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. The company's three most advanced clinical-stage development programs are BCV, ONC201 and DSTAT. BCV is an antiviral drug candidate developed as a potential medical countermeasure for smallpox and is currently under review for regulatory approval in the United States. ONC201 is currently in a registrational clinical program for recurrent H3 K27M-mutant glioma and a confirmatory response rate assessment is expected later this year. DSTAT is in development as a potential first-line therapy in acute myeloid leukemia and as a potential treatment for acute lung injury in hospitalized COVID-19 patients.
OrganizationChimerix Inc
Employees87
CEOMr. Michael A. Sherman M.B.A.
IndustryHealth Technology

Analyst Recommendation

based on 5 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 5 Wall street analysts offering stock ratings for Chimerix Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 237.84%

Current

$2.22

Target

$7.5

Recommendation Trend

Based on 5 analyst

Current1M Ago3M Ago
Buy
5
11
10
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
198.1M
Book Value
$3.11
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
1.72
PE Ratio
1.31
PEG Ratio
0.0
Wall Street Target Price
7.5

Valuation

Trailing PE1.31
Forward PE1.21
Price/Book (mrq)
0.72
Enterprise Value
-84310465
Enterprise Value/Revenue
3.57
Enterprise Value/Ebitda
1.11

Technicals

Beta
1.08
50 Day MA
1.94
200 Day MA
2.94

Institutional Holdings

Rubric Capital Management LP

7.52%

BlackRock Inc

6.55%

Vanguard Group Inc

5.1%

State Street Corporation

3.31%

Armistice Capital, LLC

3.13%

Monaco Asset Management

2.4%

Discover more

Frequently Asked Questions

What is Chimerix Inc share price today?

Can Indians buy Chimerix Inc shares?

How can I buy Chimerix Inc shares from India?

Can Fractional shares of Chimerix Inc be purchased?

What are the documents required to start investing in Chimerix Inc stocks?

What are today’s High and Low prices of Chimerix Inc?

What are today’s traded volumes of Chimerix Inc?

What is today’s market capitalisation of Chimerix Inc?

What is the 52 Week High and Low Range of Chimerix Inc?

How much percentage Chimerix Inc is down from its 52 Week High?

How much percentage Chimerix Inc is up from its 52 Week low?

What are the historical returns of Chimerix Inc?

Who is the Chief Executive Officer (CEO) of Chimerix Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*